๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Molecular therapy and prevention of liver diseases

โœ Scribed by Hubert E. Blum

Book ID
107635979
Publisher
SP Wuhan Institute of Virology, CAS
Year
2008
Tongue
English
Weight
140 KB
Volume
23
Category
Article
ISSN
1674-0769

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Treating fatty liver for the prevention
Treating fatty liver for the prevention of cardiovascular diseases
โœ Federico Salamone; Fabio Galvano; Giovanni Li Volti ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 277 KB

The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi

Valproate therapy and nonalcoholic fatty
Valproate therapy and nonalcoholic fatty liver disease
โœ Gerhard J. Luef; Markus Waldmann; Wolfgang Sturm; Anis Naser; Eugen Trinka; Iris ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB ๐Ÿ‘ 1 views

## Abstract Nonalcoholic fatty liver disease was defined recently as another symptom of insulin resistance. Continuous therapy with valproate can result in increased body weight and insulin resistance, but no data are yet available on a possible relationship between valproate and nonalcoholic fatty